One study reported increased hepatic RBP1 in human NAFLD [56], but as the authors’ highlight, increased hepatic RBP1 and other mediators of retinoid metabolism likely reflect increased flux of retinyl esters towards RA that has been observed in a number of liver diseases [56]. The gene discussed is RBP1; the disease is rheumatoid arthritis.